Medications for Advanced Melanoma
As part of our commitment to resident education, Cutis is excited to offer this monthly section with board-relevant, easy-to-review material.
This fact sheet provides a list of the current US Food and Drug Administration approved medications for treatment of metastatic melanoma, and describes their mechanism of action and any related cutaneous side effects.
After, test your knowledge by answering the 5 practice questions.
Practice Questions
1. Which of the following medications is considered an MEK inhibitor?
a. aldesleukin
b. dacarbazine
c. ipilimumab
d. recombinant interferon alfa-2b
e. trametinib
